Amgen Stock Plunges Following Disappointing Weight Loss Drug Data
A Giant’s Story: Introducing Amgen The biotechnology world buzzed with anticipation, whispers of groundbreaking treatments and potential financial windfalls swirling in the air. At the heart of this excitement stood Amgen, a titan of the industry known for its pioneering spirit and relentless pursuit of innovative medicines. However, the recent release of clinical trial data … Read more
